# R package `pvEBayes`

`pvEBayes` is an R package that implements a suite of nonparametric
empirical Bayes methods for pharmacovigilance, including the
Gamma-Poisson Shrinker (GPS), K-gamma, general-gamma, Koenker-Mizera
(KM), and Efron models. It provides tools for fitting these models to
the spontaneous reporting system (SRS) frequency tables, extracting
summaries, performing hyperparameter tuning, and generating graphical
summaries (eye plots and heatmaps) for signal detection and estimation.

**Spontaneous Reporting System (SRS) Table**: An drug safety SRS dataset
catalogs AE reports on *I* AE rows across *J* drug columns. Let $N_{ij}$
denote the number of reported cases for the *i*-th AE and the *j*-th
drug, where $i = 1,...,I$ and $j = 1,...,J$.

**Empirical Bayes modeling for disproportionality analysis**:

- Model each AE-drug count as
  $N_{ij} \sim \text{Poisson}\left( \lambda_{ij}E_{ij} \right)$.

- $E_{ij}$: expected baseline value assuming no AE-drug association.

- $\lambda_{ij} > 0$: relative reporting ratio / signal strength for the
  (i,j)-th AE-drug pair (multiplicative deviation from the null baseline
  value).

**From signal detection to signal estimation**

- Traditional disproportionality analysis emphasizes **signal
  detection**: identify AE-drug pairs with observed counts substantially
  larger than its null value, i.e., $\lambda_{ij} > 1$.

- Tan et al. (*Stat. in Med.*, 2025) extend this to **signal
  estimation**: estimate $\{\lambda_{ij}\}$ and quantify uncertainty via
  flexible nonparametric empirical Bayes posterior distribution.

- Signal estimation helps distinguish AE-drug pairs that look identical
  under a binary signal detection framework (e.g., () vs ()), which can
  have substantially different clinical implications.

**Methods implemented in `pvEBayes` (differ by prior assumptions):**

- Gamma-Poisson Shrinker (GPS)

- Koenker–Mizera method (KM)

- Efron’s nonparametric empirical Bayes approach

- K-gamma method

- General-gamma method

**Why nonparametric priors?**

- GPS uses a 2 gamma mixture prior motivated by a signal/non-signal
  structure.

- Real-world signal strengths (\_{ij}) can be heterogeneous and
  multi-modal, making simple parametric priors hard to justify.

- Nonparametric empirical Bayes methods (KM, Efron, general-gamma)
  address this challenge by utilizing a flexible prior with a general
  mixture form and estimating the prior distribution in a data-driven
  way.

**Implementation highlights:**

- Provides a fully open-source KM implementation using `CVXR` (avoids
  reliance on the commercial Mosek solver used by `REBayes`).

- Adapts Efron’s approach from `deconvolveR` to support the
  exposure/offset (E\_{ij}) in the Poisson model (not supported in the
  original implementation) .

- Implements the bi-level Expectation Conditional Maximization (ECM)
  algorithm from Tan et al. (*Stat. in Med.*, 2025) for prior estimation
  for gamma-mixture prior based models (GPS, K-gamma, general-gamma).

## Installation

The stable version of `pvEBayes` can be installed from CRAN:

    install.packages("pvEBayes")

The development version is available from GitHub:

    # if (!requireNamespace("devtools")) install.packages("devtools")
    devtools::install_github("YihaoTancn/pvEBayes")

## Quick Example

Here is a minimal example analyzing the built-in FDA statin44 dataset
with general-gamma model:

    library(pvEBayes)

    # Load the statin44 contingency table of 44 AEs for 6 statins
    data("statin2025_44")

    # Fit a general-gamma model with a specified alpha
    fit <- pvEBayes(
      contin_table      = statin2025_44,
      model             = "general-gamma",
      alpha             = 0.3,
      n_posterior_draws = 1000
    )

    # Print out a concise description of the fitted model
    fit

    # Obtain a logical matrix for the detected signal
    summary(fit, return = "detected signal")

    # Visualize posterior distributions for top AE-drug pairs
    plot(fit, type = "eyeplot")

For a more detailed illustration, please see ‘Vignette’.

## License

`pvEBayes` is released under the GPL-3 license. See ‘LICENSE.md’ for
details.

## Code of Conduct

Please note that the `pvEBayes` project is released with a [Contributor
Code of
Conduct](https://yihaotancn.github.io/pvEBayes/CODE_OF_CONDUCT.html). By
contributing to this project, you agree to abide by its terms.

## References

Tan Y, Markatou M and Chakraborty S. Flexible Empirical Bayesian
Approaches to Pharmacovigilance for Simultaneous Signal Detection and
Signal Strength Estimation in Spontaneous Reporting Systems Data.
*Statistics in Medicine*. 2025; 44: 18-19,
<https://doi.org/10.1002/sim.70195>.

Tan Y, Markatou M and Chakraborty S. pvEBayes: An R Package for
Empirical Bayes Methods in Pharmacovigilance. *arXiv*:2512.01057
(stat.AP). <https://doi.org/10.48550/arXiv.2512.01057>

Koenker R, Mizera I. Convex Optimization, Shape Constraints, Compound
Decisions, and Empirical Bayes Rules. *Journal of the American
Statistical Association* 2014; 109(506): 674–685,
<https://doi.org/10.1080/01621459.2013.869224>

Efron B. Empirical Bayes Deconvolution Estimates. *Biometrika* 2016;
103(1); 1-20, <https://doi.org/10.1093/biomet/asv068>

DuMouchel W. Bayesian data mining in large frequency tables, with an
application to the FDA spontaneous reporting system. *The American
Statistician*. 1999; 1;53(3):177-90.

# Package index

## All functions

- [`AIC(`*`<pvEBayes>`*`)`](https://yihaotancn.github.io/pvEBayes/reference/AIC.pvEBayes.md)
  : Obtain Akaike Information Criterion (AIC) for a pvEBayes object
- [`BIC(`*`<pvEBayes>`*`)`](https://yihaotancn.github.io/pvEBayes/reference/BIC.pvEBayes.md)
  : Obtain Bayesian Information Criterion (BIC) for a pvEBayes object
- [`estimate_null_expected_count()`](https://yihaotancn.github.io/pvEBayes/reference/estimate_null_expected_count.md)
  : Estimate expected null baseline count based on reference row and
  column
- [`extract_all_fitted_models()`](https://yihaotancn.github.io/pvEBayes/reference/extract_all_fitted_models.md)
  : Extract all fitted models from a tuned pvEBayes Object
- [`eyeplot_pvEBayes()`](https://yihaotancn.github.io/pvEBayes/reference/eyeplot_pvEBayes.md)
  : Generate an eyeplot showing the distribution of posterior draws for
  selected drugs and adverse events
- [`gbca2025`](https://yihaotancn.github.io/pvEBayes/reference/gbca2025.md)
  : FDA GBCA dataset with 1328 adverse events
- [`gbca2025_69`](https://yihaotancn.github.io/pvEBayes/reference/gbca2025_69.md)
  : FDA GBCA dataset with 69 adverse events
- [`generate_contin_table()`](https://yihaotancn.github.io/pvEBayes/reference/generate_contin_table.md)
  : Generate random contingency tables based on a reference table
  embedded signals,and possibly with zero inflation
- [`heatmap_pvEBayes()`](https://yihaotancn.github.io/pvEBayes/reference/heatmap_pvEBayes.md)
  : Generate a heatmap plot visualizing posterior probabilities for
  selected drugs and adverse events
- [`logLik(`*`<pvEBayes>`*`)`](https://yihaotancn.github.io/pvEBayes/reference/logLik.pvEBayes.md)
  : Extract log marginal likelihood for a pvEBayes object
- [`plot(`*`<pvEBayes>`*`)`](https://yihaotancn.github.io/pvEBayes/reference/plot.pvEBayes.md)
  : Plotting method for a pvEBayes object
- [`posterior_draws()`](https://yihaotancn.github.io/pvEBayes/reference/posterior_draws.md)
  : Generate posterior draws for each AE-drug combination
- [`print(`*`<pvEBayes>`*`)`](https://yihaotancn.github.io/pvEBayes/reference/print.pvEBayes.md)
  : Print method for a pvEBayes object
- [`pvEBayes-package`](https://yihaotancn.github.io/pvEBayes/reference/pvEBayes-package.md)
  : A suite of empirical Bayes methods to use in pharmacovigilance.
- [`pvEBayes()`](https://yihaotancn.github.io/pvEBayes/reference/pvEBayes.md)
  : Fit a general-gamma, GPS, K-gamma, KM or efron model for a
  contingency table.
- [`pvEBayes_tune()`](https://yihaotancn.github.io/pvEBayes/reference/pvEBayes_tune.md)
  : Select hyperparameter and obtain the optimal general-gamma or efron
  model based on AIC and BIC
- [`statin2025`](https://yihaotancn.github.io/pvEBayes/reference/statin2025.md)
  : FDA statin dataset with 5119 adverse events
- [`statin2025_44`](https://yihaotancn.github.io/pvEBayes/reference/statin2025_44.md)
  : FDA statin dataset with 44 adverse events
- [`statin42`](https://yihaotancn.github.io/pvEBayes/reference/statin42.md)
  : FDA statin dataset with 42 adverse events
- [`summary(`*`<pvEBayes>`*`)`](https://yihaotancn.github.io/pvEBayes/reference/summary.pvEBayes.md)
  : Summary method for a pvEBayes object

# Articles

### All vignettes

- [Introduction to
  pvEBayes](https://yihaotancn.github.io/pvEBayes/articles/pvEBayes-introduction.md):
